chlorzoxazone

Generic: chlorzoxazone

Labeler: mayne pharma commercial llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlorzoxazone
Generic Name chlorzoxazone
Labeler mayne pharma commercial llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

chlorzoxazone 500 mg/1

Manufacturer
Mayne Pharma Commercial LLC

Identifiers & Regulatory

Product NDC 51862-339
Product ID 51862-339_ffd326e9-a80a-275a-e053-6394a90a213a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211849
Listing Expiration 2026-12-31
Marketing Start 2020-07-31

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51862339
Hyphenated Format 51862-339

Supplemental Identifiers

RxCUI
197502 1088934 1088936
UPC
0351862338016 0351862340019 0351862339013
UNII
H0DE420U8G
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlorzoxazone (source: ndc)
Generic Name chlorzoxazone (source: ndc)
Application Number ANDA211849 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (51862-339-01)
source: ndc

Packages (1)

51862-339-01 100 TABLET in 1 BOTTLE (51862-339-01)

Ingredients (1)

chlorzoxazone (500 mg/1)

Linked Drug Pages (1)

Chlorzoxazone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ffd326e9-a80a-275a-e053-6394a90a213a", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0351862338016", "0351862340019", "0351862339013"], "unii": ["H0DE420U8G"], "rxcui": ["197502", "1088934", "1088936"], "spl_set_id": ["5238c99e-d36e-4376-ab05-ca2535213d58"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Mayne Pharma Commercial LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51862-339-01)", "package_ndc": "51862-339-01", "marketing_start_date": "20200731"}], "brand_name": "Chlorzoxazone", "product_id": "51862-339_ffd326e9-a80a-275a-e053-6394a90a213a", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "51862-339", "generic_name": "chlorzoxazone", "labeler_name": "Mayne Pharma Commercial LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlorzoxazone", "active_ingredients": [{"name": "CHLORZOXAZONE", "strength": "500 mg/1"}], "application_number": "ANDA211849", "marketing_category": "ANDA", "marketing_start_date": "20200731", "listing_expiration_date": "20261231"}